Australian shares are poised to end a 10-day winning streak on Friday, with the market opening down 0.2 percent at 8008 points. This decline follows a negative session on Wall Street, where the Nasdaq (NASDAQ:IXIC) experienced a drop of 1.7 percent.
Investors are once again scrutinizing ASX earnings for insights into the market's trajectory for the remainder of 2024. Focus has been on margins, with higher-quality businesses demonstrating effective cost control, as evidenced by recent earnings reports.
Key Updates:
- Telix Pharmaceuticals (ASX:TLX) has reported its first half-year profit, with shares surging more than 1300 percent over the past five years.
- Clarity Pharmaceuticals (ASX:CLZ) saw its stock rise by 3.3 percent to a record high of $7.12, marking a 580 percent increase in the past year.
- Fisher & Paykel Healthcare (ASX:FPH) has upgraded its profit guidance for fiscal 2025, leading to an 8.3 percent jump in shares.
- Latitude Financial (ASX:LFS) reported a 140 percent increase in cash profit, reaching $27 million for the six months ending June 30.
- Jumbo Interactive (ASX:JIN), the lotto operator, raised its dividend by 26.7 percent and indicated significant profit growth.
On the other hand, some stocks faced challenges:
- Accent Group (ASX:AX1) shares dropped 9 percent in early trading, following a profit report that missed expectations.
- Inghams Group (ASX:ING) experienced a 12.9 percent fall in shares due to a warning about slowing volumes.
As US Federal Reserve Chairman Jerome Powell prepares to deliver a speech at midnight AEST, market participants are keenly awaiting further economic cues.